Cardiovascular toxicities of radiotherapy: From practical issues to new perspectives
-
Published:2024-08
Issue:
Volume:197
Page:110336
-
ISSN:0167-8140
-
Container-title:Radiotherapy and Oncology
-
language:en
-
Short-container-title:Radiotherapy and Oncology
Author:
Aznar Marianne C.ORCID,
Bergler-Klein Jutta,
Boriani Giuseppe,
Cutter David J.,
Hurkmans Coen,
Levis Mario,
López-Fernández Teresa,
Lyon Alexander R.,
Maraldo Maja V.
Reference50 articles.
1. Cancer treatment and survivorship statistics, 2022;Miller;CA Cancer J Clin,2022
2. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the european society of cardiology (ESC);Zamorano;Eur Heart J,2016
3. 2022 ESC guidelines on cardio-oncology developed in collaboration with the european hematology association (EHA), the european society for therapeutic radiology and oncology (ESTRO) and the international cardio-oncology society (IC-OS);Lyon;Eur Heart J,2022
4. Past, present, and future of radiation-induced cardiotoxicity: refinements in targeting, surveillance, and risk stratification;Bergom;JACC CardioOncol,2021
5. Cardiovascular manifestations from therapeutic radiation: a multidisciplinary expert consensus statement from the international cardio-oncology society;Mitchell;JACC CardioOncol,2021